Radiofrequency Ablation Versus Hemithyroidectomy for Small Thyroid Cancers

This is a multicenter randomized controlled trial including patients with small (\<2 cm) suspected or confirmed thyroid cancers. Patients are included after informed consent and randomized to one of two treatments. One treatment is a standard henithyroidectomy and the second treatment is radiofrequency ablation (RFA) of the specific tumor. The investigators will evaluate initial outcome of the allocated treatment, thyroid hormonal function, oncologic safety, quality of life, and treatment costs in a follow-up period of five years after treatment. The overall aim of the study is to improve pat

Trial Details

NCT ID

NCT06796348

Phase

NA

Sponsor

University of Aarhus

Status

RECRUITING

Cancer Type

Thyroid Cancer

Interventions

• Radiofrequency ablation alone
• Surgery

Locations (sample)

• Aarhus, Denmark|56.15674,10.21076

Key Eligibility Criteria

• Single tumor in the thyroid gland with a FNAB suspecious of cancer or diagnostic of cancer (category V or VI in the Bethesda system)
• tumor size of less than 2 cm in all dimensions.

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Thyroid Cancer Trials on Trialify →